Pharmaceutical industry calls Clinton plan wrong

November 2000
Employee Benefit News;Nov2000, Vol. 14 Issue 13, p80
Reports that the Pharmaceutical Research and Manufacturers of America (PhRMA) has criticized the United States government's proposal regarding prescription drug costs for seniors. Overview of the PhRMA study; Solution suggested by PhRMA to market drug coverage for seniors.


Related Articles

  • Efforts to dictate prices are destined to fail. Bohanon, Cecil; Styring, Bill // Indianapolis Business Journal;9/14/2015, Vol. 36 Issue 29, p21 

    In this article, the authors presents their views on whether the Indiana government's efforts to control prices is justified and how it affects people and economy.

  • Notes.  // BMJ: British Medical Journal (International Edition);3/18/89, Vol. 298 Issue 6675, p761 

    Reports developments in health and medicine in Great Britain as of March 18, 1989. Increase in prescription charges; Research fellowships in toxicology by the European Science foundation; Details on the inaguaral meeting of the British Sleep Society.

  • Prescription charges rise by 20p.  // British Medical Journal (Clinical Research Edition);3/5/1988, Vol. 296 Issue 6623, p728 

    Focuses on the increase of National Health Service (NHS) prescription charges in Great Britain. Effect on the increasing cost of medicine to the rise in prescription charges; View of the Labor party on the increase; Rate of dental charges for overseas visitors.

  • Dumping insurance price controls will ultimately benefit... Berrington, Craig A. // National Underwriter / Property & Casualty Risk & Benefits Manag;11/17/97, Vol. 101 Issue 46, p25 

    Reports on the price controls that McCarran-Ferguson spawned in almost every state in the United States which is a system of pervasive governmental intrusion. Reason why the system of governmental price control for property and casualty insurance has been a failure; Reason for the enforcement...

  • Washington letter.  // DCI;Apr94, Vol. 154 Issue 4, p10 

    Reports on the lack of astonishment at the Generic Pharmaceutical Industry Association's praise of the Clinton administration for its health care proposal.

  • Washington letter.  // DCI;May94, Vol. 154 Issue 5, p10 

    Reports that the Nonprescription Drug Manufacturers Association has asked the Food and Drug Administration to abandon the effective date for unsealed hard gelatin capsules.

  • Washington letter.  // DCI;Jun94, Vol. 154 Issue 6, p10 

    Reports on Pharmaceutical Manufacturers Association's changing of its name to Pharmaceutical Research & Manufacturers of America in an effort to distance itself from the generic drug industry. Focus of the association on drug research; Association's effort to fight generic prescribing;...

  • PMA changes name and focus to stress its research roots. Conlan, Michael F. // Drug Topics;5/23/94, Vol. 138 Issue 10, p62 

    Reports that the Pharmaceutical Manufacturers Association has changed its name to the Pharmaceutical Research and Manufacturers of America (PhRMA). Highlights of PhRMA's annual meeting; Appointment of Stephen R. Conafy as the vice president of strategic and legislative affairs; Expansion of the...

  • Associations discuss merger possibility.  // Drug Topics;9/4/95, Vol. 139 Issue 17, p7 

    Reports that leaders of the American Managed Care Pharmacy Association and the Academy of Managed Care Pharmacy have discussed the possibility of merging.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics